Brexpiprazole CAS 913611-97-9 Tsarkake>99.0% (HPLC) Kamfanin API

Takaitaccen Bayani:

Sunan sinadarai: Brexpiprazole

Saukewa: 913611-9

Tsafta:> 99.0% (HPLC)

Bayyanar: Fari ko Kashe-White Crystalline Foda

API High Quality, Kasuwancin Kasuwanci

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari Brexpiprazole
Makamantu OPC-34712;7- (4- (4- (Benzo [b]thiophen-4-yl)piperazin-1-yl)butoxy) quinolin-2 (1H) -daya
Lambar CAS 913611-97-9
Lambar CAT RF-PI1982
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C25H27N3O2S
Nauyin Kwayoyin Halitta 433.57
Yawan yawa 1.245± 0.060 g/cm3
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari ko Kashe-White Crystalline Foda
Ganewa By IR
RT A karkashin chirality ya kamata a bi
Chloride Yana ba da amsawar chloride
Ruwa 3.0% ~ 4.5%
Matsayin narkewa 198.0 ~ 202.0 ℃
Ragowa akan Ignition <0.20%
Karfe masu nauyi ≤10ppm
Abubuwa masu alaƙa
Rashin Tsabtace Mutum <0.50%
Jimlar ƙazanta <1.00%
EE >99.0%
Tsarkake / Hanyar Bincike > 99.0% (HPLC, akan busassun tushe)
Matsayin Gwaji Matsayin Kasuwanci
Amfani API

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

Brexpiprazole (CAS: 913611-97-9) ɗan takarar magani ne mai amfani a cikin jiyya da rigakafin rikice-rikicen tunani ciki har da cututtukan CNS.Brexpiprazole wani sabon magani ne na antipsychotic wanda ke aiki azaman mai sarrafa ayyukan serotonin ® dopamine kuma ya nuna inganci azaman jiyya na haɗin gwiwa a cikin marasa lafiya tare da babban rashin damuwa (MDD).Brexpiprazole yana nuna bayanin martaba na musamman na likitanci, yana aiki azaman agonist na yanki na serotonin 5-HT1A da dopamine D2 masu karɓa kuma a matsayin cikakken antagonist na 5-HT2A da noradrenaline α1B/2C masu karɓa, tare da alaƙar ɗaurin subnanomolar iri ɗaya.Brexpiprazole Otsuka da Lundbeck ne suka haɓaka, an amince da su a cikin 2015 ta FDA don maganin schizophrenia kuma a matsayin ƙarin magani don damuwa.An yi la'akari da Brexpiprazole a matsayin magajin Otsuka's antipsychotic miyagun ƙwayoyi aripiprazole (sunan ciniki Abilify) wanda ikon mallaka ya ƙare a watan Agusta 2014.

Ku rubuta sakonku anan ku aiko mana